ArticleJournal of autoimmunity2019

Utilizing a PTPN22 gene signature to predict response to targeted therapies in rheumatoid arthritis.

Hui-Hsin Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.